Abstract: Anemia is common in African children but little is known about how malarial anemia influences Plasmodium falciparum gametocyte sex ratios (PfGSR) and transmission in endemic areas in Africa. We investigated the changes in PfGSR in 1126 consecutive children with acute, symptomatic, uncomplicated falciparum malaria who did (n = 99) or did not (n = 1027) have anemia (defined as a hematocrit < 25%) and who were treated with various antimalarial drugs in an endemic area of southwest Nigeria. On presentation, anemic children were significantly younger and had a significantly higher PfGSR (0.28 + 0.07 (se) v 0.15 + 0.02, P = 0.044). In anemic, but not in non-anemic children, a duration of illness > 3 d was associated with a male-biased sex ratio (defined as PfGSR > 0.5) (P = 0.029). Hematocrit correlated negatively with PfGSR in non-anemic but not in anemic children (r = -0.219, P = 0.027 and r = -0.106, P = 0.697, respectively) suggesting that the critical hematocrit producing 'all or none effect' on PfGSR was a value below 25% in this cohort of children. Temporal changes showed that, in general, in anemic children, PfGSR was significantly higher at enrolment than in non-anemic children treated with chloroquine (CQ), amodiaquine (AQ) and amodiaquine-sulfalene-pyrimethamine (ASP) (P < 0.0007 in all cases), and remained significantly higher by day 7 or 14 in those treated with AQ and pyrimethaminesulfadoxine plus probenecid (PSP) (P < 0.007 in all cases). In children who received the same treatment, the ratio of the sex specific half-life male:female, the 'gametocyte maleness index', was one and a half to two folds higher in anemic than non-anemic children suggesting anemia prolongs the survival of microgametocytes and may encourage transmission. These findings have implications for malaria control efforts in endemic sub-Saharan countries where malarial anemia is common.
INTRODUCTION
Anemia is common in African children and is multifactorial in origin [1] . In these children, falciparum malaria is an important cause of acute and a major contributor to chronic anemia [2, 3] . In African children with acute P. falciparum infections, gametocyte carriage varies from 8-17% [4] [5] [6] . In these children, many variables contribute to the risk for gametocyte carriage amongst which is anemia [5] .
Many variables, for example, high gametocyte density, a male biased sex ratio, antimalarial drugs or sensitivity to drugs have been shown to enhance gametocyte infectivity to mosquitoes [7] [8] [9] [10] [11] . Although anemia is an important cause of a male-biased gametocyte sex ratio [12, 13] , little is known about how malarial anemia influences Plasmodium falciparum gametocyte sex ratios (PfGSR) and transmission in endemic areas of Africa. Such information is necessary to optimize control.
In order to address these issues in an area of intense transmission, we investigated the changes in PfGSR in 1126 consecutive children with acute, symptomatic, uncomplicated falciparum malaria who did or did not have anemia *Address correspondence to this author at the Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria; Tel: +234-80233-59390; E-mail: akinsowunmi@hotmail.com (defined as a hematocrit < 25%) in an endemic area of southwest Nigeria. Our aims were to: determine the contribution of anemia to PfGSR on presentation; determine the factors associated with a male biased PfGSR in children who did or did not have anemia on presentation; and evaluate the temporal changes in PfGSR in children following treatment with antimalarial drugs in these children.
PATIENTS AND METHODS
Patients were recruited from 1999-2006 at the malaria clinic of the University College Hospital in Ibadan, southwest Nigeria, an endemic area of malaria [14] , into various antimalarial efficacy studies and were enrolled if the following criteria were met: an age 0.5-14 years, fever or history of fever in the 24-48 h preceding presentation, pure Plasmodium falciparum parasitaemia > 2000/ l blood, absence of concomitant illness, negative urine tests for 4-aminoquinoline (Dill-Glazko) and sulfonamides (lignin), and written informed consent of a parent or guardian. Patients with severe malaria [15] or serious underlying diseases (renal, cardiac or hepatic) or severe malnutrition were excluded from the study. The studies received approval from the local ethics committee.
Drug treatment was according to standard schedules (Table 1). At enrolment (day 0) and at follow-up on days 1-7, Quantification of asexual and sexual parasites in thick films was done against 500 and 1000 leukocytes, respectively assuming a leukocyte count of 6000/ l blood. All gametocytes were sexed if gametocytaemia > 10/ l blood and according to the following criteria [16] : males (microgametocytes) are smaller than females (macrogametocytes), the nucleus is larger in males than females, the ends of the cells are rounder in males and angular in females, with Giemsa the cytoplasm stains purple in males and deep blue in females, and the granules of malaria pigment are centrally located in females and more widely scattered in males. The sex ratio was defined as the proportion of gametocytes in peripheral blood that were male [17] . A gametocyte sex ratio was considered male-biased if it was > 0.5.
The half-life of gametocyte sex was determined using a non-compartmental pharmacokinetic model as previously described [18, 19] . Sex specific half-lives were determined only in patients who had gametocytaemia at enrolment and for at least three times during the first 7-14 days after enrolment and were analyzed only in patients who had a hematocrit value consistently below 25% or consistently > 25% during the first 7-14 days of commencing therapy. Gametocyte maleness index (GMI) was defined as the ratio of sex specific half-life male:female. This ratio was determined for patients with or without anemia in each drug treatment group.
DATA ANALYSIS
Data were analyzed using version 6 of the Epi-Info software [20] , and the statistical programme SPSS for Windows version 10.01 [21] . Variables considered in the analysis were related to the densities of P. falciparum gametocytes and trophozoites. Proportions were compared by calculating 2 with Yates' correction or by Fisher exact or by Mantel Haenszel tests. Normally distributed, continuous data were compared by Student's t-tests and analysis of variance (ANOVA). Data not conforming to a normal distribution were compared by the Mann-Whitney U-tests and the Kruskal-Wallis tests (or by Wilcoxon ranked sum test). The relationship between gametocyte sex ratio and clinical or parasitological parameters was assessed by linear regression. A univariate analysis was used to determine the factors, clinical or parasitological, associated with a male biased PfGSR. Because the study was conducted over a period of eight years, time in years since the commencement of the study was included as a dichotomous variable, that is, before 2004 and 2004 onward. All tests of significance were two-tailed. P-values of < 0.05 were taken to indicate significant differences. Data were (double)-entered serially using the patients' codes and were only analyzed at the end of the study.
RESULTS

Patient Characteristics at Enrolment
During the study period, 1126 children were enrolled and followed up for at least 21 days. The characteristics of the children with and without anemia are shown in Table 2 . Children with anemia were significantly younger, weighed significantly less and had a significantly longer duration of illness.
Therapeutic Responses
The immediate therapeutic responses are also summarized in Table 2 . Fever, but not parasite clearance, was significantly shorter in the non-anemic children.
Gametocyte Carriage and Sex Ratios at Enrolment
Overall, at enrolment, gametocytes were found in the peripheral blood of 118 children (10.5%) (geometric mean gametocyte density 18/ l, range 6-366). Overall, 89% of the gametocytes counted could be sexed. Gametocyte carriage was nearly significantly higher in anemic compared to the non-anemic children (16 of 99 v 102 of 1027, P = 0.053) ( Table 2) . PfGSR was significantly higher in anemic than non-anemic children (0.28 + 0.07 (se) v 0.15 + 0.02 (se), P = 0.044) ( Table 2) . Table 3 shows that a duration of illness > 3 d and enrolment before 2004 were significantly associated with a malebiased sex ratio at enrolment in children with anemia. In Anemia defined as PCV < 25 %. FCT, fever clearance time; GMPD, geometric mean parasite density; GMGD, geometric mean gametocyte density; GSR, gametocyte sex ratio; PCT, parasite clearance time; N, number; sd, standard deviation; se, standard error of mean.
Factors Associated with a male Biased Gametocyte Sex Ratio at Presentation
contrast, only enrolment before 2004 was associated with a male-biased sex ratio in children without anemia. Table 4 is a summary of the correlation analyses between hematocrit and the clinical and other parasitological parameters in children with or without anemia. In anemic children, there was no significant correlation between hematocrit and clinical or parasitological parameters. In contrast, in children without anemia, hematocrit was positively or negatively correlated with age, duration of illness, weight, parasite density or PfGSR.
Relationship between Gametocyte Sex Ratio and Clinical or Parasitological Parameters on Presentation
Gametocyte Densities before, During, and after Treatment with Antimalarial Drugs Table 5 is a summary of gametocyte densities pre-and post-treatment in anemic and non-anemic children. In both groups of children following treatment with CQ, AQ or PS, post-treatment densities were significantly higher than pretreatment densities but the increases were much more significant in the non-anemic than the anemic children. In other treatment groups, the number of anemic and non-anemic children was too few to make meaningful conclusions.
Temporal Changes in Gametocyte Sex Ratios Following Treatment
Following therapy, in 30 and 258 anemic and non anemic children, respectively in whom 5137 and 34481 gametocytes were sexed, respectively, the mean sex ratio was 0.35 (95%CI 0.19-0.51) on day 3, 0.63 (95%CI 0.47-0.79) on day 7 and 0.75 (95%CI 0.52-0.98) (P = 0.00000003) by day 14 after therapy commenced in the anemic group, and 0.36 (95%CI 0.29-0.43) on day 3, 0.72 (95%CI 0.63-0.81) on day 7 and 0.72 (95%CI 0.64-0.79) (P = 0.00000002) by day 14 after therapy commenced in the non-anemic group (Fig. 1a) . Fig. (1b) shows the temporal changes in gametocyte sex ratios following treatment with CQ, AQ or ASP. In those treated with CQ or AQ, post-treatment GSR was significantly higher in the anemic than the non-anemic children from days 0-7 or 14 (P < 0.007 in all cases). In other treatment groups, the number of anemic and non-anemic children was too few to make meaningful conclusions. 
Influence of Drug Treatment on the Half-Life of Gametocyte Sexes
We estimated, using a non-compartment model, the halflife of gametocyte sexes in all treatment groups. Table 6 shows that ratio of the sex specific half life male:female, the 'gametocyte maleness index' (GMI), in anemic and nonanemic children treated with CQ, AQ and PS. In general, GMI in anemic children was one and a half to two folds higher than in non-anemic children.
DISCUSSION
In this study, the overall 'anemia rate', defined as hematocrit less than 25%, in children with acute falciparum malaria was 9%. This rate is considerably lower than 40%, were a hematocrit less than 30% were used in this cohort of children. Our justification for the cut off was based on recent studies that showed a hematocrit less than 25% was a predictor of a male-biased PfGSR in malarious children from this endemic area [22] . Overall, the gametocyte carriage rate of 16% in anemic children was almost significantly higher than the 10% in the non-anemic group ( Table 2) . This would suggest anemia predisposes these children to gametocyte carriage and supports finding from others areas of Africa and elsewhere [5, 23] . Submicroscopic gametocytaemia, detectable by polymerase chain reaction (PCR), is not uncommon in children undergoing antimalarial therapy [11, 24] . Therefore, our overall estimates of gametocyte carriage in anemic and non-anemic children are likely to be underestimates.
In this study, the overall sex ratio at enrolment was 0.18, in keeping with natural population [12] but PfGSR was twice as high in the anemic as the non-anemic children. Since a higher PfGSR increases the chances of mosquito infectivity [8] , this would suggest anemic children are at higher risk of infecting mosquitoes. In addition, the higher gametocyte carriage rate in anemic children may mean that they constitute a larger reservoir of infection than the non-anemic children. Taken together, both factors may enhance transmission of infection by anemic children in the population. The reasons for the higher PfGSR in anemic children are not readily apparent from our results, but erythropoietin levels have been shown to increase the sex ratio in animals [12] . Studies comparing the kinetics of the secretion and elimination of erythropoietin in anemic and non-anemic African children are urgently needed.
The factors associated with a male biased PfGSR in anemic and non-anemic children were similar. However a longer duration of illness was associated with a male biased PfGSR in anemic children. The reasons for this are unclear. In natural infections in animals sex ratio often increase over the course of infections [12, 25] . Since a longer duration of illness is a predictor of anemia in malaria [26] , it would appear the relatively longer duration of the untreated infections in anemic children allow a faster progression of a natural change of increase in PfGSR. The lack of correlation between hematocrit and PfGSR in anemic children and the significantly negative correlation in the non-anemic children, Mean gametocyte sex ratio suggest that, in this cohort of children, the critical haematocrit threshold producing 'all or none effect' on GSR was a value below 25%.
Following therapy, in general, the temporal changes in PfGSR were similar in anemic and non-anemic children: both gametocyte densities and PfGSR increased significantly. This could be explained by the fact that in both groups, drug treatment increased both gametocyte density, and contributed equally to the increase in PfGSR. However, the background effect of anemia on PfGSR was still evident in patients treated with chloroquine, and amodiaquine. In this subgroup of patients, following therapy, PfGSR was significantly elevated in the anemic than in the non-anemic group for up to7-14 days.
In an attempt to discern the mechanism(s) of the anemiainduced increases in PfGSR, we determined the half-life of gametocyte sexes. In the present study, the gametocyte maleness index in anemic children was one and a half to two folds greater than in non-anemic children treated with similar drugs. This would suggest anemia preferentially prolonged the half-life of male gametocytes perhaps by encouraging their release into, and survival in the circulation. There are advantages in using the GMI: it allows assessment of the effects of each drug on gametocyte sexes; its application is independent of any definition of a male-biased sex ratio; it is a summation of several processes-drug, parasite and patient factors; it may be used to evaluate the effects of other factors on gametocyte sex ratios.
The study has several limitations that should be addressed in future studies. First, the study did not evaluate other potential association of male-biased PfGSR such as history of antimalarial drug use. Some antimalarials, for example, antifolates may produce a male biased PfGSR [27] . Second, anemia is often multi-factorial [1, 3] . In this regard the contribution of co-infection with helminths to the anemia of malaria was not evaluated. In addition, co-infection with helminths may be associated with increased gametocyte carriage [28] . Another limitation was the levels of erythropoietin in the individual patients were not measured making it difficult to relate the levels directly to PfGSR.
There are potential applications of our findings: In addition to other causes, anemia in falciparum malaria is related to antimalarial drug resistance and treatment failure [26] . Therefore, prompt treatment of acute malaria infections with effective non-anemia and non-gametocytaemia-inducing drugs such as the artemisinin derivatives [19, 22, 29, 30] should reduce the burden of malarial anemia; community control of infections and anemia should reduce the risk of gametocyte carriage and a male biased PfGSR and burden of malaria transmission. 
